NASDAQ
Arbutus Biopharma Corporation (ABUS) has a current ratio of 15.73x as of Monday, May 25, 2026. This represents a 90.97% increase compared to its 12-month average of 8.24x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.